MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-06-2025
iTeos Therapeutics PEG Ratio 2011-2026 | ITOS
Annual PEG Ratio iTeos Therapeutics
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | -0.295 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.295 | -0.295 | -0.295 |
PEG Ratio of other stocks in the Biotechnology industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
-0.169 | - | 2.43 % | $ 254 M |  Germany |
 |
Acorda Therapeutics
ACOR
|
-0.000047 | - | -24.86 % | $ 820 K |  USA |
 |
Adverum Biotechnologies
ADVM
|
-0.00407 | - | - | $ 86.2 M | USA |
 |
Amgen
AMGN
|
5.35 | $ 345.02 | 1.52 % | $ 186 B | USA |
 |
AlloVir
ALVR
|
0.1 | - | 4.14 % | $ 49.1 M | USA |
 |
Amneal Pharmaceuticals
AMRX
|
-0.293 | $ 12.59 | 2.19 % | $ 3.95 B | USA |
 |
Applied Molecular Transport
AMTI
|
0.133 | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
0.243 | - | - | $ 8.42 M | USA |
 |
argenx SE
ARGX
|
0.081 | $ 777.72 | 1.61 % | $ 25 B |  Niderland |
 |
I-Mab
IMAB
|
-0.75 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
-0.747 | - | - | $ 40.3 B | USA |
 |
Genfit SA
GNFT
|
-0.0281 | - | 2.54 % | $ 160 B |  France |
 |
Arcutis Biotherapeutics
ARQT
|
0.0316 | $ 23.65 | 1.63 % | $ 3.01 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
0.0594 | $ 1.43 | 4.78 % | $ 381 M |  Britain |
 |
AVROBIO
AVRO
|
0.068 | - | 1083.1 % | $ 745 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.0783 | - | - | $ 7.46 M |  Israel |
 |
AstraZeneca PLC
AZN
|
-369 | - | - | $ 96.9 B | Britain |
 |
Midatech Pharma plc
MTP
|
-0.0114 | - | -18.52 % | $ 27.3 M | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
0.254 | - | -1.52 % | $ 24.7 M | USA |
 |
BeiGene, Ltd.
BGNE
|
9.68 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Alterity Therapeutics Limited
ATHE
|
-0.0509 | $ 3.86 | 2.74 % | $ 9.29 B |  Australia |
 |
BioNTech SE
BNTX
|
-12.8 | $ 91.14 | 1.7 % | $ 27.2 B | Germany |
 |
CymaBay Therapeutics
CBAY
|
-24.1 | - | - | $ 3.45 B | USA |
 |
Advaxis
ADXS
|
-0.000022 | - | -9.65 % | $ 45.9 M | USA |
 |
Aytu BioScience
AYTU
|
-0.00324 | $ 2.66 | 3.5 % | $ 16.7 M | USA |
 |
Burford Capital Limited
BUR
|
-0.568 | $ 4.73 | 4.07 % | $ 775 M | Britain |
 |
Avid Bioservices
CDMO
|
0.0439 | - | - | $ 789 M | USA |
 |
Cidara Therapeutics
CDTX
|
-0.00298 | - | - | $ 1.41 B | USA |
 |
Cabaletta Bio
CABA
|
-0.01 | $ 3.1 | 0.97 % | $ 311 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
-2.8 | - | - | - |  Russia |
 |
Checkpoint Therapeutics
CKPT
|
-0.00928 | - | - | $ 169 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
6.6 | $ 3.03 | - | $ 6.59 B | Israel |
 |
Aeterna Zentaris
AEZS
|
0.0493 | - | 5.93 % | $ 314 M |  Canada |
 |
Checkmate Pharmaceuticals
CMPI
|
0.189 | - | - | $ 231 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.51 | - | -10.17 % | $ 12.2 K | USA |
 |
Cerus Corporation
CERS
|
0.951 | $ 1.95 | 5.99 % | $ 372 M | USA |
 |
Concert Pharmaceuticals
CNCE
|
0.0149 | - | - | $ 401 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-0.0134 | - | - | $ 1.01 B | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.00894 | - | - | $ 26.5 M | USA |
 |
Cellectar Biosciences
CLRB
|
-0.00121 | $ 2.8 | 1.82 % | $ 7.3 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
4.94 | - | - | $ 1.2 B | USA |
 |
AIkido Pharma
AIKI
|
-0.000778 | - | 1.93 % | $ 17.4 M | USA |
 |
Aptose Biosciences
APTO
|
-0.000164 | - | -45.71 % | $ 1.2 M | Canada |
 |
Deciphera Pharmaceuticals
DCPH
|
1.4 | - | - | $ 2.18 B | USA |
 |
Akero Therapeutics
AKRO
|
-0.964 | - | - | $ 3.67 B | USA |
 |
Dynavax Technologies Corporation
DVAX
|
-0.688 | - | - | $ 2.02 B | USA |
 |
CureVac N.V.
CVAC
|
4.05 | - | - | $ 867 M | Germany |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-0.0104 | $ 9.61 | -1.06 % | $ 128 M | USA |